(CNN) — The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription ...

Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat ...

(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s ...

Joint pain can be caused by a number of biological, psychological, and social factors. The most common cause of joint pain is ...

Explore the full archive of TIME, a century of journalism, insight, and perspective, with AI that helps you research, connect ...

WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals. The drug, Journavx, or suzetrigine, was approved to treat moderate to severe acute ...

Nerve pain affects millions of people worldwide, creating a burning, shooting, or electric sensation that can make daily activities nearly impossible. Unlike regular pain that responds well to common ...

(NEW YORK) — The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx ...